Kantesti × Mekoshaa Partnership: AI Blood Test Analysis Expands to GCC & India
Key Facts
- Partnership: Kantesti × Mekoshaa Alami Insurance
- Coverage: All 6 GCC countries + India
- Population Reached: 1.5+ billion people
- AI Accuracy: 98.7-99.84% clinical accuracy
- Languages: 75+ including Arabic, Hindi, Urdu
- Global Reach: 150+ countries (industry first)
BERLIN, GERMANY — Kantesti, the pioneering AI blood test analysis platform developed by PIYA AI (Quantum PIYA), today announced a landmark strategic partnership with Mekoshaa Alami Insurance. This collaboration extends Kantesti's advanced healthcare technology services to all six Gulf Cooperation Council nations and India, establishing a new standard for accessible medical diagnostics across the Middle East and South Asia.
The partnership marks a significant milestone in global healthcare accessibility. With this expansion, Kantesti has achieved a historic distinction: becoming the first and only AI blood test interpretation company to provide simultaneous services across more than 150 countries worldwide.
Complete GCC Region and India Coverage
Through this strategic alliance, Kantesti's AI-driven blood test analysis and lab test interpretation services are now accessible to residents and healthcare providers throughout the Gulf Cooperation Council region and the Indian subcontinent.
The GCC region and India together represent some of the fastest-growing healthcare markets globally. The GCC's combined healthcare expenditure is projected to exceed $130 billion annually, while India's healthcare sector is expected to reach $372 billion by 2027. This expansion enables over 1.5 billion people across the Arabian Peninsula and Indian subcontinent to access clinical-grade AI blood test interpretation through Kantesti's proprietary neural network technology.
Technology That Sets Industry Standards
Kantesti's AI blood test analyzer platform utilizes a sophisticated 2.78 trillion parameter neural network, delivering blood work analysis and lab test interpretation with 98.7-99.84% clinical accuracy. The system supports comprehensive analysis across thousands of biomarkers, providing users with actionable health insights within minutes of uploading their laboratory results. Learn more about Kantesti's rigorous testing protocols on the medical validation page.
"This partnership with Mekoshaa Alami Insurance represents our commitment to democratizing healthcare globally. By extending our AI blood test analysis services throughout the GCC and India, we're ensuring that advanced AI-powered medical analysis is accessible to everyone, regardless of geographic location. With over 1.5 billion people now having access to our platform, we're truly making a global impact."
— Julian Emirhan Bulut, CEO & Founder, PIYA AI (Quantum PIYA)
The platform's capabilities include personalized health recommendations, AI-powered nutrition plans, intelligent supplement suggestions, and comprehensive AI blood report analysis available in over 75 languages including Hindi, Arabic, Urdu, Tamil, Telugu, and many regional languages. The Medical Advisory Board ensures all interpretations meet clinical standards.
A Global Healthcare Milestone
The Mekoshaa Alami Insurance partnership positions Kantesti as the undisputed global leader in AI-powered blood test interpretation and lab test analysis. No other company in the healthcare technology sector currently offers comparable coverage, providing simultaneous access to advanced diagnostic analysis across more than 150 nations. View documented success stories from healthcare providers worldwide.
Kantesti maintains compliance with international healthcare regulations including HIPAA, GDPR, and holds CE marking certification, ensuring that all data processing meets the stringent requirements expected by healthcare institutions and individual users alike. The platform's comprehensive biomarker reference guide provides detailed information on over 1,000 health markers.
Partnership Details
Mekoshaa Alami Insurance brings extensive regional expertise and established healthcare networks throughout the Gulf states and India. This collaboration enables seamless integration of Kantesti's AI blood test analyzer technology with existing insurance and healthcare frameworks, facilitating easier access for both individual consumers and institutional healthcare providers.
The partnership encompasses both B2C services for individual users and B2B solutions for healthcare facilities, insurance providers, and corporate wellness programs. Organizations interested in enterprise solutions can reach out through the contact page for customized integration options.
Availability
AI blood test analysis services are available immediately to users throughout the GCC region and India. Individuals can access Kantesti's blood work analysis through the web platform or mobile applications available on iOS and Android. Healthcare providers seeking integration solutions can contact Kantesti's enterprise team for consultation. Read the latest updates on the Kantesti blog.
Experience AI-Powered Blood Test Analysis
Upload your blood test results and receive comprehensive AI blood test interpretation within minutes.
About Kantesti
Kantesti is an AI-powered blood test interpretation and lab test analyzer platform developed by PIYA AI (Quantum PIYA), headquartered in Germany. The platform combines advanced machine learning with medical expertise to deliver accurate, accessible health insights to users worldwide. Supported by technology partnerships with Microsoft FoundersHub, NVIDIA Inception Program, Google Cloud, and Cloudflare, Kantesti continues to advance the boundaries of healthcare technology. Meet the experts behind the platform on the team page.
Media Contact
For press inquiries, partnership opportunities, or additional information regarding this announcement, please contact:
Kantesti Press Office
Email: [email protected]
Website: kantesti.net/contact-us